Short Interest in Poxel S.A. (OTCMKTS:PXXLF) Declines By 95.0%

Poxel S.A. (OTCMKTS:PXXLF) saw a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 100 shares, a decline of 95.0% from the August 15th total of 2,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Poxel Stock Performance

Shares of OTCMKTS:PXXLF remained flat at $0.70 during trading on Friday. Poxel has a 12 month low of $0.55 and a 12 month high of $0.70. The firm’s 50-day simple moving average is $0.70 and its two-hundred day simple moving average is $0.66.

About Poxel

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.